In addition to reducing the risk of a missed diagnosis, experts say this double testing approach has the potential to reduce demand for colonoscopies in a healthcare system under pressure.
Geneoscopy submitted a Premarket Approval application to the FDA for its noninvasive, at-home screening test to detect colorectal cancer.
While screening by Fecal Immunochemical Test can detect colon cancer, successful treatment depends on patients do a follow up colonoscopy.
Younger adults in the U.S. are less likely to be screened for colorectal cancer than older adults despite now being eligible for screening.
Read More
The SENTiFITÂ 800 Analyzer is designed to help meet the growing need of colorectal cancer screening organizations and clinical laboratories.
Read More
Researchers developed a blood test that may change how chemo is used for colon cancer, by identifying those who can safely spare treatment.
Read More
Geneoscopy assessed the health outcomes associated with an investigational RNA-FIT biomarker panel for colorectal cancer screenings.
Read More
Freenome completed the enrollment for PREEMPT CRC, a large, prospective study to validate its blood test for colorectal cancer screening.
Read More
AI reduced the rate at which precancerous polyps were missed in colorectal cancer screening by twofold, according to new research.
Read More
A new systematic review of colorectal cancer explored predictors of screening adherence among average risk adults across three decades.
Read More
Everly Health has detailed its capability to provide colorectal cancer preventive screening at scale.
Read More
Colorectal cancer disparities between Black and white adults were eliminated following a structured colorectal cancer screening program, a new study found.
Read More
Check Cap is developing new, low-invasive ingestible capsule technology that aims to address issues associated with preventive screenings for colonoscopies.
Read More
Phillips-Medisize provides end-to-end manufacturing support to Exact Sciences, developers of the FDA-approved Cologuard at-home colorectal screening test.
Read More
The number of colorectal cancer cases diagnosed fell dramatically by 40% in a year during the COVID-19 pandemic.
Read More
The DiaCarta ColoScape assay detects precancerous colorectal cancer lesions and colorectal cancer mutations with high sensitivity, according to a new study.
Read More
A survey of colorectal cancer screening patients found a preference for at-home fecal occult blood testing over colonoscopy during the COVID-19 pandemic.
Read More
Researchers have developed noninvasive tests that use either blood or saliva samples to diagnose colorectal cancer or prostate cancer, respectively.
Read More